Humana Sinks 13% as CMS Proposes Medicare Advantage Audit Crackdown
SentiSense · Published · Updated
Humana shares fell 13% to $385.78 on Wednesday, November 18, their worst day since January, after CMS proposed a rule that would expand Medicare Advantage risk-adjustment audits. UnitedHealth fell 10.2% the same day.
HUM shares closed down 13% at $385.78 on Wednesday, November 18, the stock's worst single-day drop since January. Seeking Alpha had reported the stock down about 9% earlier in the session on the proposed Medicare fraud crackdown, and the decline took the shares below their 50-day moving average.
The trigger is a proposed CMS rule, published Monday, November 16, that would let the agency extrapolate risk-adjustment (RADV) audit findings across entire Medicare Advantage contracts. CMS has framed the package as a fraud crackdown and estimates recoveries of about $9 billion per payment year. Extrapolated audits go straight at insurer economics, because a sample of disputed coding can be scaled into a contract-wide repayment.
The selling was sector-wide. UNH fell 10.2% to $349.91 on the same day, after also falling on Tuesday, and Elevance and CVS Health declined as well. Humana, whose business is concentrated in Medicare Advantage, fell the most.
What to watch: the rule is a proposal, and comments run until January 19, 2027, so the final text could change. Investors will look for company commentary on potential repayment exposure, any litigation, and whether the drawdown in Medicare Advantage names stabilizes once the scope of the audits is clearer.
Related Stocks
Powered by SentiSense - Intelligent Market Analysis